A shocking investigation by Tamil Nadu’s Drug Control Department has laid bare the severe and systemic failures at the manufacturing unit responsible for producing Coldrif cough syrup, a product linked to the tragic deaths of at least 15 children in Madhya Pradesh and Rajasthan. The probe reveals a facility operating in utter disregard for safety norms, mired in filth and procedural illegalities.
A Facility in Disarray
Following the alarming reports of child fatalities, a drug control team conducted a thorough inspection of the syrup manufacturing plant located in Tamil Nadu. What they uncovered was a catalog of over 350 violations. The official report paints a grim picture of unhygienic conditions, with the medicine being produced amid filth. The company was found to be critically deficient in nearly every aspect required for safe pharmaceutical manufacturing: skilled manpower, proper machinery, adequate facilities, and necessary equipment were all severely lacking.
The Presence of Toxic Substances
The investigation confirmed the presence of toxic substances—propylene glycol and diethylene glycol—in the syrup. While propylene glycol is a common and generally safe pharmaceutical ingredient, its toxicity can increase in high quantities. The probe alarmingly noted that the company had illegally purchased 50 kilograms of propylene glycol without proper invoicing, a major red flag that suggests attempts to bypass regulatory oversight.
More critically, the report highlights the dangerous and sometimes fatal practice of substituting propylene glycol with its cheaper industrial cousin, diethylene glycol. Diethylene glycol is a solvent commonly used in brake fluid, paint, and plastics and is highly toxic to humans. It has no place in food or medicine, yet its substitution has been the cause of multiple mass poisoning tragedies across the globe, including the recent incident in Chhindwara, Madhya Pradesh.
A Trail of Tragedy and a Nationwide Alert
The human cost of this negligence is devastating. So far, at least 15 children, mostly under the age of five, have lost their lives in Madhya Pradesh and Rajasthan after consuming the contaminated syrup. Reports indicate the victims suffered acute kidney failure, a known consequence of diethylene glycol poisoning.
In response to the deaths, several states have intensified health safety measures. While Madhya Pradesh grapples with the immediate aftermath, other states have taken proactive steps:
Kerala issued a directive advising that no medicine be given to children under 12 without a doctor's prescription.
Karnataka’s health department has recommended that hospitals avoid prescribing or dispensing cough and cold syrups to children under two years old.
Jharkhand has taken the strictest action, imposing a complete ban on the sale, purchase, and use of three cough syrups, including Coldrif, Respifresh, and Relife.
Leave Your Comment